Key facts
- Status: Privately Held (backing).
- ·Watchlist + deal alerts for NanoOnco
- ·The full record, as it builds
Funding rounds
No funding rounds for NanoOnco are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About NanoOnco
Developer of a bioabsorbable magnesium device designed to control cancer and cancer metastasis. The company's system includes a novel insertion device and an ultrasound feature to monitor the placement of wires in a tumor with minimal tissue damage and pain, and low costs, enabling the healthcare industry to deliver anti-cancer treatment into the tumor while reducing harmful effects on the body.
- Sector
- Healthcare
- HQ
- Ann Arbor, MI, United States
- Founded
- 2025
- Website
- nanoonco.com/
- Ownership
- Privately Held (backing)
NanoOnco doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in NanoOnco shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on NanoOnco in its N-PORT filings yet. We sweep new filings monthly.